SMS Pharmaceuticals Bilan de santé
Santé financière contrôle des critères 4/6
SMS Pharmaceuticals possède un total de capitaux propres de ₹5.6B et une dette totale de ₹2.9B, ce qui porte son ratio d'endettement à 50.6%. Son actif total et son passif total sont ₹11.3B et de ₹5.7B. L'EBIT de SMS Pharmaceuticals est ₹955.7M ce qui fait que son ratio de couverture des intérêts 5. Elle dispose de liquidités et de placements à court terme de ₹90.7M.
Informations clés
50.6%
Ratio d'endettement
₹2.85b
Dette
| Ratio de couverture des intérêts | 5x |
| Argent liquide | ₹90.66m |
| Fonds propres | ₹5.64b |
| Total du passif | ₹5.71b |
| Total des actifs | ₹11.35b |
Mises à jour récentes de la santé financière
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22Recent updates
Risks Still Elevated At These Prices As SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Shares Dive 25%
Nov 14SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You
Jul 04Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Analyse de la situation financière
Passif à court terme: Les actifs à court terme de SMSPHARMA ( ₹5.8B ) dépassent ses passifs à court terme ( ₹3.8B ).
Passif à long terme: Les actifs à court terme de SMSPHARMA ( ₹5.8B ) dépassent ses passifs à long terme ( ₹2.0B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de SMSPHARMA ( 49% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de SMSPHARMA est passé de 43.2% à 50.6% au cours des 5 dernières années.
Couverture de la dette: La dette de SMSPHARMA est bien couverte par le flux de trésorerie opérationnel ( 22.9% ).
Couverture des intérêts: Les paiements d'intérêts de SMSPHARMA sur sa dette sont bien couverts par l'EBIT ( 5 x couverture).